The European market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index declining by 0.98% amid ongoing trade and geopolitical uncertainties, reflecting broader challenges in major indices such as France's CAC 40 and Germany's DAX. Despite these headwinds, investors continue to seek opportunities within the tech sector, where high growth potential can often be found by focusing on companies with strong innovation capabilities and robust business models that can navigate economic fluctuations effectively.
Top 10 High Growth Tech Companies In Europe
| Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
|---|---|---|---|
| Hacksaw |
28.53% |
33.50% |
★★★★★★ |
| Pharma Mar |
16.39% |
34.00% |
★★★★★☆ |
| Bonesupport Holding |
25.63% |
57.97% |
★★★★★★ |
| KebNi |
25.19% |
61.24% |
★★★★★★ |
| CD Projekt |
32.94% |
48.67% |
★★★★★★ |
| Kitron |
21.22% |
32.45% |
★★★★★★ |
| SyntheticMR |
18.81% |
47.40% |
★★★★★☆ |
| Comet Holding |
10.94% |
38.32% |
★★★★★☆ |
| Waystream Holding |
17.38% |
66.50% |
★★★★★☆ |
| Gapwaves |
29.76% |
59.76% |
★★★★★☆ |
Let's explore several standout options from the results in the screener.
Smartoptics Group
Simply Wall St Growth Rating:★★★★☆☆
Overview:Smartoptics Group ASA delivers optical networking solutions and devices across various regions including the Americas, Europe, the Middle East, Africa, and the Asia-Pacific, with a market cap of NOK2.89 billion.
Operations:The company focuses on providing optical networking solutions and devices across multiple regions, with a significant presence in the Americas, Europe, the Middle East, Africa, and Asia-Pacific.
Smartoptics Group, a player in the optical communications sector, has shown promising growth with a 46.5% increase in quarterly sales year-over-year and significant strides in net income from $0.537 million to $1.37 million as of Q3 2025. The company's engagement with the IOWN Global Forum underscores its strategic commitment to next-generation photonics and optical networks, positioning it well within an industry pushing towards ultra-low latency and energy-efficient solutions. This aligns with their recent technological advancements demonstrated by Glesys' adoption of Smartoptics' IP over DWDM systems for enhanced network capabilities. With revenue forecasted to grow at 19.5% annually, outpacing the Norwegian market's 2%, and earnings expected to surge by 55.5% per year, Smartoptics is navigating an upward trajectory amidst a competitive tech landscape.
Dustin Group
Simply Wall St Growth Rating:★★★★☆☆
Overview:Dustin Group AB (publ) operates as an online information technology company across Sweden, Finland, Denmark, the Netherlands, Norway, and Belgium with a market capitalization of approximately SEK2.44 billion.
Operations:Dustin Group AB (publ) generates revenue primarily from the Large Corporate and Public Sector (LCP) segment, which accounts for SEK15.53 billion. The company's market presence spans Sweden, Finland, Denmark, the Netherlands, Norway, and Belgium.
Dustin Group, navigating through a challenging tech landscape, reported a significant reduction in net loss to SEK 26 million from SEK 78 million year-over-year and increased sales by approximately 14.7% to SEK 5.487 billion in Q1 2026. This marks a notable recovery with basic and diluted loss per share improving from SEK 0.1 to SEK 0.02, reflecting tighter cost management and operational efficiency. With an expected revenue growth of 3.5% annually outpacing the Swedish market's contraction, coupled with an anticipated surge in earnings by an impressive annual rate of nearly 111.84%, Dustin is poised for profitability within three years despite recent shareholder dilution and current unprofitability challenges.
-
Navigate through the intricacies of Dustin Group with our comprehensive health report here.
-
Review our historical performance report to gain insights into Dustin Group's's past performance.
RaySearch Laboratories
Simply Wall St Growth Rating:★★★★★☆
Overview:RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment globally, with a market capitalization of approximately SEK7.08 billion.
Operations:RaySearch Laboratories generates revenue primarily from its healthcare software segment, which accounted for SEK1.29 billion. The company's focus on providing software solutions for cancer treatment positions it within the medical technology sector.
RaySearch Laboratories, a leader in oncology software and treatment planning, is demonstrating robust growth with a 13.9% annual increase in revenue and an impressive 24.3% rise in earnings per year. The company's commitment to innovation is evident from its R&D spending, which has consistently been above industry average, fostering advancements like the RayStation® treatment planning system. Recent strategic hires and expanded partnerships, such as with Wielkopolskie Centrum Onkologii for advanced cancer care using proton therapy, underscore its strategic intent to enhance global healthcare capabilities through cutting-edge technology.
-
Dive into the specifics of RaySearch Laboratories here with our thorough health report.
-
Explore historical data to track RaySearch Laboratories' performance over time in our Past section.
Seize The Opportunity
-
Click this link to deep-dive into the 48 companies within our European High Growth Tech and AI Stocks screener.
-
Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
-
Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Seeking Other Investments?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
-
Find companies with promising cash flow potential yet trading below their fair value .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OB:SMOP OM:DUST and OM:RAY B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
